On November 15, CooperVision expanded its prior recall of nearly 5 million contact lenses to include a second Avaira brand. The original recall was in August of this year. The second brand of Avaira may be contaminated with silicone oil residue. The silicone residue is linked to eye injuries, blurred vision, and severe pain.
According to the MSNBC News, CooperVision added more of their contact lenses to the recall because particular lots of the contact lenses failed to meet quality standards due to the oil residue. CooperVision Inc. produced 6.6 million Avaira Sphere lenses, which are affected by the recall. Fortunately, only 4.9 million of those recalled contact lenses were actually shipped.
The FDA issued a Class I warning, warning that the contact lenses could be contaminated with the oil residue. The Class I warning forced the company to increase the public notification regarding the recall of 780,000 Avaira Toric Lenses.
The most serious kind of recalls are Class I recalls. Class I recalls are issued when there is a likely and reasonable chance of serious adverse health consequences; in some cases, death.
In October, the FDA received about 40 reports of issues associated with various contact lenses from CooperVision. At least 15 mentioned Avaira Toric and at least two mentioned Avaira Sphere.
There have been many reports from these recalled contact lenses causing people to go to the hospital. Some of the reported problems include hazy vision, severe pain, and torn corneas.
CooperVision is expected to spend $23.2 million on the contact lenses recall.
If you or someone you love has experienced symptoms of hazy vision and a torn cornea from using CooperVision contacts, you may want to contact our attorneys at Childers, Schlueter & Smith at.
